GMO

Jeremy Grantham

Period

Q1 2026

Portfolio Date

Mar 31, 2026

Stocks Held

626

Market Value

$38.9B

Portfolio Analysis

AIPreview
Full report in app

I. Institutional Overview

The institutional investment landscape is often defined by the tension between short-term market momentum and long-term fundamental reality. Few institutions embody the latter as consistently as GMO (Grantham, Mayo, & van Otterloo), the firm co-founded by the legendary investor Jeremy Grantham. As of the portfolio snapshot dated March 31, 2026, GMO’s...

Jeremy Grantham has long been regarded as a "bubble historian," a title earned through his uncanny ability to identify periods of irrational exuberance, from the Japanese asset price bubble of the late 1980s to the dot-com crash and the 2008 financial crisis. However, the GMO portfolio is not merely a reflection of a bearish outlook. Instead, it reveals a...

The current scale of $38.94 billion suggests that GMO remains a titan in the institutional space, capable of moving markets through its thematic shifts. The sheer number of stocks—over 600—indicates that while the firm makes high-conviction bets on "Quality" mega-caps, it also maintains a broad exposure to various factors, likely managed through systematic...

Based on the latest available 13F filing.

Open full report in app

Holdings Value Trend

Q2 2024

Q3 2024

Q4 2024

Q1 2025

Q2 2025

Q3 2025

Q4 2025

Q1 2026

Historical Positions

SymbolQ1 2026Q4 2025Q3 2025Q2 2025
MSFT5.8%6.5%7.2%7.3%
GOOGL5.1%5.3%4.8%4.2%
JNJ4.5%3.8%3.6%3.0%
AAPL4.5%4.7%4.4%3.7%
META4.5%4.9%4.7%4.9%
LRCX3.8%4.1%3.7%2.8%
AMZN3.3%3.8%--
TMO3.1%3.6%2.9%-
AVGO2.6%2.8%2.6%-
USB2.5%---

Post-Filing Contributors

Price change since reported price, ranked by portfolio contribution

GOOGL+24.42%
TXN+53.81%
LRCX+69.67%
UNH+49.88%
AMZN+15.96%

Post-Filing Detractors

Price change since reported price, ranked by portfolio contribution

ABT-12.68%
ACN-15.52%
TMO-3.23%
JNJ-2.50%
CRM-10.61%

Sector Analysis

Energy2.3%
Others0.1%
Materials2.6%
Utilities0.4%
Financials10.3%
Healthcare23.8%
Technology31.9%
Industrials3.0%